Staying the course after first progression yields better mRCC survivalFebruary 10, 2017Renal Cell CarcinomaGenitourinary Cancer
GU Cancers Symposium to feature latest on immune checkpoint inhibitors, circulating tumor cellsFebruary 7, 2017Genitourinary Cancer
Antiandrogen therapy improves survival after biochemical recurrence of prostate cancerFebruary 1, 2017Genitourinary Cancer
ASCO offers practice guidance on small renal massesJanuary 19, 2017Genitourinary CancerClinical GuidelinesRenal Cell Carcinoma
AKT inhibition not superior to everolimus for RCCJanuary 10, 2017Genitourinary CancerRenal Cell Carcinoma
Adjuvant chemo prolonged survival after radical nephroureterectomyJanuary 9, 2017Genitourinary Cancer
Vaccine/PD-1 inhibitor combo shows early promise against mCRPCNovember 29, 2016Genitourinary CancerImmunotherapy
ADT not associated with increased risk of dementia in larger studyNovember 21, 2016Genitourinary Cancer
Cabozantinib bests sunitinib against metastatic RCCNovember 14, 2016Genitourinary CancerRenal Cell Carcinoma
Cancer survivors report two times greater medication use for anxiety and depressionOctober 26, 2016Patient & Survivor CareMelanomaGynecologic CancerBreast CancerGastroenterologyGenitourinary CancerMixed Topics
